Literature DB >> 25482604

Sensitive detection of aggregated prion protein via proximity ligation.

Maria Hammond1, Lotta Wik, Jean-Philippe Deslys, Emmanuel Comoy, Tommy Linné, Ulf Landegren, Masood Kamali-Moghaddam.   

Abstract

The DNA assisted solid-phase proximity ligation assay (SP-PLA) provides a unique opportunity to specifically detect prion protein (PrP) aggregates by investigating the collocation of 3 or more copies of the specific protein. We have developed an SP-PLA that can detect PrP aggregates in brain homogenates from infected hamsters even after a 10(7)-fold dilution. In contrast, brain homogenate from uninfected animals did not generate a detectable signal at 100-fold higher concentration. Using either of the 2 monoclonal anti-PrP antibodies, 3F4 and 6H4, we successfully detected low concentrations of aggregated PrP. The presented results provide a proof of concept that this method might be an interesting tool in the development of diagnostic approaches of prion diseases.

Entities:  

Keywords:  263K; BSE, bovine spongiform encephalopathy; CJD, Creutzfeldt-Jakob disease; CSF, cerebrospinal fluid; FIDA, fluorescence intensity distribution analysis; PLA, proximity ligation assay; PMCA, protein misfolding cyclic amplification; PrP, prion protein; PrPC, cellular prion protein; PrPSc, scrapie prion protein; QuIC, quaking-induced conversion; SP-PLA, solid phase proximity ligation assay; diagnosis; monoclonal antibody; prion protein; proximity ligation assay; qPCR, quantitative real-time PCR

Mesh:

Substances:

Year:  2014        PMID: 25482604      PMCID: PMC4601298          DOI: 10.4161/pri.32231

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  33 in total

1.  A novel method for preclinical detection of PrPSc in blood.

Authors:  Richard Rubenstein; Binggong Chang; Perry Gray; Martin Piltch; Marie S Bulgin; Sharon Sorensen-Melson; Michael W Miller
Journal:  J Gen Virol       Date:  2010-03-31       Impact factor: 3.891

2.  Sensitive discrimination and detection of prion disease-associated isoform with a dual-aptamer strategy by developing a sandwich structure of magnetic microparticles and quantum dots.

Authors:  Sai Jin Xiao; Ping Ping Hu; Xiao Dong Wu; Yan Li Zou; Li Qiang Chen; Li Peng; Jian Ling; Shu Jun Zhen; Lei Zhan; Yuan Fang Li; Cheng Zhi Huang
Journal:  Anal Chem       Date:  2010-11-01       Impact factor: 6.986

3.  Sensitive plasma protein analysis by microparticle-based proximity ligation assays.

Authors:  Spyros Darmanis; Rachel Yuan Nong; Maria Hammond; Jijuan Gu; Anders Alderborn; Johan Vänelid; Agneta Siegbahn; Sigrun Gustafsdottir; Olle Ericsson; Ulf Landegren; Masood Kamali-Moghaddam
Journal:  Mol Cell Proteomics       Date:  2009-11-27       Impact factor: 5.911

4.  Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion.

Authors:  Ryuichiro Atarashi; Katsuya Satoh; Kazunori Sano; Takayuki Fuse; Naohiro Yamaguchi; Daisuke Ishibashi; Takehiro Matsubara; Takehiro Nakagaki; Hitoki Yamanaka; Susumu Shirabe; Masahito Yamada; Hidehiro Mizusawa; Tetsuyuki Kitamoto; Genevieve Klug; Amelia McGlade; Steven J Collins; Noriyuki Nishida
Journal:  Nat Med       Date:  2011-01-30       Impact factor: 53.440

5.  A highly sensitive immunoassay for the detection of prion-infected material in whole human blood without the use of proteinase K.

Authors:  M Howard Tattum; Samantha Jones; Suvankar Pal; Azedeh Khalili-Shirazi; John Collinge; Graham S Jackson
Journal:  Transfusion       Date:  2010-12       Impact factor: 3.157

6.  Human variant Creutzfeldt-Jakob disease and sheep scrapie PrP(res) detection using seeded conversion of recombinant prion protein.

Authors:  Christina D Orrú; Jason M Wilham; Andrew G Hughson; Lynne D Raymond; Kristin L McNally; Alex Bossers; Ciriaco Ligios; Byron Caughey
Journal:  Protein Eng Des Sel       Date:  2009-07-01       Impact factor: 1.650

7.  Application of a novel in vitro selection technique to isolate and characterise high affinity DNA aptamers binding mammalian prion proteins.

Authors:  David F Bibby; Andrew C Gill; Louise Kirby; Christine F Farquhar; Moira E Bruce; Jeremy A Garson
Journal:  J Virol Methods       Date:  2008-04-23       Impact factor: 2.014

8.  Optical trapping with high forces reveals unexpected behaviors of prion fibrils.

Authors:  Jijun Dong; Carlos E Castro; Mary C Boyce; Matthew J Lang; Susan Lindquist
Journal:  Nat Struct Mol Biol       Date:  2010-11-28       Impact factor: 15.369

9.  Sensitive detection of Aβ protofibrils by proximity ligation--relevance for Alzheimer's disease.

Authors:  Masood Kamali-Moghaddam; Frida Ekholm Pettersson; Di Wu; Hillevi Englund; Spyros Darmanis; Anna Lord; Gholamreza Tavoosidana; Dag Sehlin; Sigrun Gustafsdottir; Lars N G Nilsson; Lars Lannfelt; Ulf Landegren
Journal:  BMC Neurosci       Date:  2010-10-05       Impact factor: 3.288

10.  Immunopurification of pathological prion protein aggregates.

Authors:  Emiliano Biasini; Laura Tapella; Susanna Mantovani; Matteo Stravalaci; Marco Gobbi; David A Harris; Roberto Chiesa
Journal:  PLoS One       Date:  2009-11-12       Impact factor: 3.240

View more
  3 in total

Review 1.  Proximity ligation assay: an ultrasensitive method for protein quantification and its applications in pathogen detection.

Authors:  Pengzhi Wang; Yi Yang; Tianqi Hong; Guoqiang Zhu
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-11       Impact factor: 4.813

2.  Homogeneous and digital proximity ligation assays for the detection of Clostridium difficile toxins A and B.

Authors:  Harvinder S Dhillon; Gemma Johnson; Mark Shannon; Christina Greenwood; Doug Roberts; Stephen Bustin
Journal:  Biomol Detect Quantif       Date:  2016-08-31

3.  Accurate detection of Newcastle disease virus using proximity-dependent DNA aptamer ligation assays.

Authors:  Boutheina Marnissi; Khouloud Khalfaoui; Tonge Ebai; Felipe Marques Souza de Oliveira; Abdeljelil Ghram; Masood Kamali-Moghaddam; Issam Hmila
Journal:  FEBS Open Bio       Date:  2021-03-11       Impact factor: 2.693

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.